1

Eyetech Pharmaceuticals

Eyetech Pharmaceuticals
Leadership team

Anthony P. Adamis (Founder)

David Guyer (Founder)

Marty Glick (Founder)

Products/ Services
Biopharma, Biotechnology, Medical
Number of Employees
100 - 500
Headquarters
New York, New York, United States
Established
1997
Traded as
NASDAQ:EYET
Overview
Location
Summary
EyeTech Pharmaceuticals is a world-leading R&D-focused biopharmaceutical company specializing in developing innovative products that improve and extend the lives of people living with serious diseases in ophthalmology.
History

Founded in 2013 and headquartered in Pennsylvania, EyeTech Pharma is focused on developing and commercializing transformative treatments for patients with serious and potentially blinding eye diseases and conditions. As the first dedicated eye care biopharmaceutical company in the world, EyeTech Pharma leverages its clinical and scientific expertise to develop therapeutics that tackle a variety of ocular diseases. EyeTech Pharma has built a strong R & D infrastructure to develop and commercialize products across the ophthalmology management spectrum.

Mission
EyeTech Pharma’s mission is to develop and commercialize innovative treatments that will improve the quality of life of patients who suffer from serious and potentially blinding eye diseases and conditions.
Vision
EyeTech Pharma’s vision is to be a leader in ophthalmology and revolutionize the way we diagnose and treat ocular diseases.
Key Team

Samir Patel (Founder)

Recognition and Awards
EyeTech Pharma has won numerous awards and recognition for its pioneering work in the field of ophthalmology, including the Prix Galien Innovation Award and the National Ophthalmic Research Award. The company has also been named to the 2016 Global Top 10 list of biopharmaceutical companies by Forbes.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Eyetech Pharmaceuticals
Leadership team

Anthony P. Adamis (Founder)

David Guyer (Founder)

Marty Glick (Founder)

Products/ Services
Biopharma, Biotechnology, Medical
Number of Employees
100 - 500
Headquarters
New York, New York, United States
Established
1997
Traded as
NASDAQ:EYET